Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels

Gaens, Katrien H. J., Ferreira, Isabel, van der Kallen, Carla J. H., van Greevenbroek, Marleen M. J., Blaak, Ellen E., Feskens, Edith J. M., Dekker, Jacqueline M., Nijpels, Giel, Heine, Robert J., 't Hart, Leen M., de Groot, Philip G., Stehouwer, Coen D. A. and Schalkwijk, Casper G. (2009) Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. Journal of Clinical Endocrinology and Metabolism, 94 12: 5174-5180. doi:10.1210/jc.2009-1067


Author Gaens, Katrien H. J.
Ferreira, Isabel
van der Kallen, Carla J. H.
van Greevenbroek, Marleen M. J.
Blaak, Ellen E.
Feskens, Edith J. M.
Dekker, Jacqueline M.
Nijpels, Giel
Heine, Robert J.
't Hart, Leen M.
de Groot, Philip G.
Stehouwer, Coen D. A.
Schalkwijk, Casper G.
Title Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels
Journal name Journal of Clinical Endocrinology and Metabolism   Check publisher's open access policy
ISSN 0021-972X
1945-7197
Publication date 2009
Year available 2009
Sub-type Article (original research)
DOI 10.1210/jc.2009-1067
Open Access Status
Volume 94
Issue 12
Start page 5174
End page 5180
Total pages 7
Place of publication Chevy Chase, MD United States
Publisher The Endocrine Society
Language eng
Abstract Objective: The receptor for advanced glycation end products (RAGE)-ligand interaction has been linked to vascular complications. The family of soluble forms of RAGE (sRAGE) consists of splice variants and proteolytically cleaved and shed forms of RAGE. sRAGE may be a reflection of cell-bound RAGE. Because genetic variation in the RAGE gene may be associated with individual differences in sRAGE concentration and outcome, we investigated whether RAGE single-nucleotide polymorphisms (SNPs) were associated with circulating levels of sRAGE. Methods: Nine SNPs, covering the common RAGE gene variation, were genotyped in a Dutch cohort of subjects with normal glucose metabolism (n = 301), impaired glucose metabolism (n = 127), and type 2 diabetes mellitus (n = 146). We used linear regression analyses adjusted for age, sex, and glucose metabolism status to compare sRAGE levels across genotypes. Results: SNP rs2060700 (Gly82Ser) showed an association with sRAGE levels. Specifically, after adjustments for age, sex, and glucose metabolism, subjects with CT genotype had -527 pg/ml(95% confidence interval -724 to -330, P < 0.001) lower sRAGE levels compared with the CC genotype (age, sex, and glucose metabolism adjusted mean ± SE values of 836 ± 99 and 1369 ± 26 pg/ml, respectively, P < 0.001). These results were confirmed in a subsample of a second cohort study of subjects with CT (n = 37) and CC genotype (n = 37). Immunoblotting using antibodies against amino acids 39-55 and 100-116 of RAGE also showed a similar decrease of sRAGE levels in the CT genotypes. No other SNPs showed an association with sRAGE levels. In addition, no associations between SNPs and the advanced glycation end products Nε- (carboxymethyl)lysine and Nε-(carboxyethyl) lysine were found. Conclusion: The CC genotype of SNP rs2070600 (Gly82Ser) was strongly associated with higher sRAGE levels in a Dutch population. The mechanism by which Gly82Ser polymorphism alters the sRAGE levels remains to be elucidated. Copyright
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Public Health Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 50 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 55 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 20 May 2015, 16:47:08 EST by Isabel Ferreira on behalf of School of Public Health